Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO Prescribed by AMM in Prostate Cancer

NCT04516707 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.

NCT NCT04516707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04516707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO Prescribed by AMM in Prostate Cancer
Lead sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
May 1, 2018
Enrollment
67 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, hormone-resistant prostate cancer, prostate cancer